We wish you a truly happy holiday season, and we look forward to seeing you again in the new year.
About Tina Dackemark Lawesson
This author has yet to write their bio.Meanwhile lets just say that we are proud Tina Dackemark Lawesson contributed a whooping 28 entries.
Entries by Tina Dackemark Lawesson
Our CEO presented at Vator Unicorn Summit in Stockholm last week and in the video below you can watch him explaining about SenzaGen’s change from a research organization to one with a strong focus on commercialization. Vator Unicorn Summit, November 27, 2019
In case you missed us at Biostock in Stockholm yesterday, CEO Axel Sjöblad explains SenzaGen’s commercialization and how the rights issue is part of the company’s growth strategy in these video clips. Presentation Biostock Live, Dec 3, 2019 Interview Biostock Live, Dec 3, 2019
Lyssna på SenzaGens VD Axel Sjöblad via klippet nedan – om att ta bolaget från ett forskningsbolag till ett lönsamt kommersiellt bolag. SenzaGen på Småbolagsjakten i Stockholm den 27 november.
Tack alla som kom och lyssnade på VD Axel Sjöblads presentation av SenzaGens skifte från forskningsbolag till kommersiellt bolag och den pågående företrädesemissionen på Stora Aktiedagen i Stockholm den 25 november 2019. Missade du presentationen så kan du se den här:
We are proud to welcome PKDerm as GARD® distributor. Located in Grasse, France, PKDerm offers innovative in vitro solutions to pharmaceutical, dermo-cosmetic and chemical industries in order to evaluate the efficacy and safety of products likely to come into contact with the skin. “As a GARD distributor, we are excited to offer a solution to […]
E. Schmidt, V. Zuckerstätter, H. Gehrke | Eurofins BioPharma Product Testing Munich GmbH Introduction A skin sensitiser refers to a substance that will lead to an allergic response following skin contact as defined by the United Nations Globally Harmonized System of Classification and Labelling of Chemicals (UN GHS). The potential to induce skin sensitisation is […]
This pilot study demonstrated the applicability of the GARDTMskin assay for identification of skin sensitizers in hair dye ingredients, delivering high prediction performance, consistent with existing human data. The study also indicated that GARDTMskin is a promising in vitro model to identify skin sensitizers in natural mixtures. Link to Application Note.
Rose-Marie Jenvert, Angelica Johansson, Olivia Larne, Emelie Danefur, Emil Altonen, Anders Jerre, Robin Gradin, Gunilla Grundström. SenzaGen, Lund, Sweden. Introduction All medical devices need to be evaluated for the end point skin sensitization according to the Biological Evaluation of Medical Devices (ISO 10993-1:2018), today commonly involving in vivo assays. Here, we show that the in […]
Olivia Larne, Ulrika I Torstensdotter Mattson, Rikard Alm, and Gunilla Grundström. SenzaGen, Lund, Sweden. Introduction The GARD®skin assay is an in vitro assay developed for the assessment of skin sensitizers. It is based on SenzaCells™, a human dendritic-like cell line, and a biomarker signature analyzed by a prediction model including pattern recognition and machine learning. […]